ABN Amro Upgrades Core Laboratories (CLB) to Buy

October 25, 2017 6:18 AM

ABN Amro upgraded Core Laboratories (NYSE: CLB) from Hold to Buy with a price target of $117.50 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found